SCHEMBL13969296

SCHEMBL13969296

c1ccc(-n2c3ccccc3c3cc(-c4ccc(N(c5ccc(-c6ccc(N(c7ccc(-c8ccc(N(c9ccc(-c%10ccc%11c(c%10)c%10ccccc%10n%11-c%10ccccc%10)cc9)c9cccc%10ccccc9%10)cc8)cc7)c7ccc(-n8c9ccccc9c9ccccc98)cc7)cc6)cc5)c5cccc6ccccc56)cc4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TSPO P30536 5/20 0.37
▸ PTGER4 P35408 1/20 0.36
▸ HDAC4 P56524 1/20 0.35
▸ PTGES O14684 1/20 0.32
▸ NPY5R Q15761 2/20 0.31
▸ MAPK8 P45983 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ IL1R1 P14778 1/20 0.30
▸ SIGMAR1 Q99720 1/20 0.30
▸ CNR1 P21554 1/20 0.30
▸ CNR2 P34972 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ SIRT2 Q8IXJ6 1/20 0.30
▸ SIRT1 Q96EB6 1/20 0.30
▸ RXRA P19793 1/20 0.30
▸ RXRB P28702 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13968543 0.99 KDM4E (0.44) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13130932 0.99 KDM4E (0.44) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13968523 0.99 KDM4E (0.44) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13968537 0.99 KDM4E (0.44) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122277 0.98 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL10309926 0.98 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122274 0.98 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122270 0.98 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL22966151 0.98 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13125995 0.98 L3MBTL1 (0.45) KDM4EATML3MBTL1TSPOPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246441-B2 Aromatic amine derivative, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2019-04-02 — — US disclosed
US-20120292606-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2012-11-22 — — US disclosed
US-20120292606-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2012-11-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246441-B2 Aromatic amine derivative, and organic electroluminescent element MAOB, MAOA, NAT1 KDM4E 433/4885ATM 696/4885L3MBTL1 1183/4885
US-20120292606-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT MAOB, MAOA, NAT1 KDM4E 433/4885ATM 696/4885L3MBTL1 1183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback